findmyKOL

Wenyi Zhang, MD

Basic profile

Endocrinology, Diabetes & Metabolism

ORCID↗NPI↗
RegionRenton, WA · WestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Wenyi Zhang is an Endocrinology/Metabolic physician. OpenAlex indexes 20 publications with 396 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
20publications

Distinct works indexed by OpenAlex, matched via ORCID.

396citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

660 SW 39th St Ste 150
Renton, WA 98057

Telephone

425-690-3485

Registry record last updated 19 Aug 2019.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    64.4%
    Insulin Analog21.8%
    Lantus Solostar37%Humalog Kwikpen U-10012%Insulin Lispro Kwikpen U-10010%Novolog Flexpen10%Tresiba Flextouch U-1009%Basaglar Kwikpen U-1007%Levemir Flexpen5%Novolog3%Humalog2%Lantus2%Fiasp Flextouch2%
    Part D<11 patients
    GLP-1 receptor agonist13.7%
    Ozempic83%Trulicity17%
    Part D≥64 patients

    + 8 more classes in this area

  • Hormonal (systemic)

    24.9%
    l-Thyroxine19.2%
    Levothyroxine Sodium90%Synthroid11%
    Part D≥127 patients
    Thyroid Hormone Synthesis Inhibitor4.4%
    Methimazole100%
    Part D≥35 patients

    + 2 more classes in this area

  • Cardiovascular

    8.5%
    Statin5.5%
    Atorvastatin Calcium91%Rosuvastatin Calcium10%
    Part D<11 patients
    ACE inhibitor1.6%
    Lisinopril100%
    Part D≥12 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”